CFTR and chronic obstructive pulmonary disease: Moreover, the smoke-impaired CFTR function of mice could be completely reversed after oral administration of roflumilast for five weeks, further implicating the CFTR activation as a mechanism by which COPD patients with CB benefits from roflumilast treatment [29].